medigraphic.com
Asociación Mexicana de Gastroenterología

2007, Número 4

<< Anterior Siguiente >>

Rev Gastroenterol Mex 2007; 72 (4)


Nutrition in hepatic failure and liver transplantation

Sanchez AJ, Aranda-Michel J

Idioma: Ingles.
Referencias bibliográficas: 44
Paginas: 365-370
Archivo PDF: 49.07 Kb.


RESUMEN

La enfermedad hepática crónica predispone a alteraciones metabólicas que conducen a la malnutrición, la cual se evidencia de manera universal en los pacientes con insuficiencia hepática que se someten a un trasplante de hígado y está asociada con un incremento en la morbilidad y la mortalidad. El estado nutricional es un factor importante para la supervivencia luego del trasplante hepático. El soporte nutricional intenso es esencial durante todas las fases del trasplante hepático. Este artículo de revisión explora los problemas nutricionales que ocurren en pacientes con insuficiencia hepática, poniendo énfasis en la evaluación y el soporte nutricional antes y después del trasplante hepático.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Lochs H, Plauth M. Liver cirrhosis: rationale and modalities for nutritional support-the European Society of Parenteral and Enteral Nutrition consensus and beyond. Curr Opin Clin Nutr Metab Care 1999; 2(4): 345-9.

  2. McCullough AJ, Bugianesi E. Protein-calorie malnutrition and the etiology of cirrhosis. Am J Gastroenterol 1997; 92(5): 734-8.

  3. Hasse JM. Nutritional implications of liver transplantation. Henry Ford Hosp Med J 1990; 38(4): 235-40.

  4. Greco AV, Mingrone G, Benedetti G, Capristo E, Tataranni PA, Gasbarrini G. Daily energy and substrate metabolism in patients with cirrhosis. Hepatology 1998; 27(2): 346-50.

  5. Zoli M, Marchesini G, Dondi C, Bianchi GP, Pisi E. Myofibrillar protein catabolic rates in cirrhotic patients with and without muscle wasting. Clin Sci (Lond) 1982; 62(6): 683-6.

  6. Andersen H, Borre M, Jakobsen J, Andersen PH, Vilstrup H. Decreased muscle strength in patients with alcoholic liver cirrhosis in relation to nutritional status, alcohol abstinence, liver function, and neuropathy. Hepatology 1998; 27(5): 1200-6.

  7. Yamanaka H, Genjida K, Yokota K, Taketani Y, Morita K, Miyamoto KI, Miyake H, Tashiro S, Takeda E. Daily pattern of energy metabolism in cirrhosis. Nutrition 1999; 15(10): 749-54.

  8. Nishida T, Tsuji S, Tsujii M, Arimitsu S, Haruna Y, Imano E, Suzuki M, Kanda T, Kawano S, Hiramatsu N, Hayashi N, Hori M. Oral glucose tolerance test predicts prognosis of patients with liver cirrhosis. Am J Gastroenterol 2006; 101(1): 70-5.

  9. Muller MJ, Pirlich M, Balks HJ, Selberg O. Glucose intolerance in liver cirrhosis: role of hepatic and non-hepatic influences. Eur J Clin Chem Clin Biochem 1994; 32(10): 749-58.

  10. McCullough AJ, Raguso C. Effect of cirrhosis on energy expenditure. Am J Clin Nutr 1999; 69(6): 1066-8.

  11. Campos AC, Matias JE, Coelho JC. Nutritional aspects of liver transplantation. Curr Opin Clin Nutr Metab Care 2002; 5(3): 297-307.

  12. Mathur S, Peng S, Gane EJ, McCall JL, Plank LD. Hypermetabolism predicts reduced transplant-free survival independent of MELD and Child-Pugh scores in liver cirrhosis. Nutrition 2007; 23(5): 398-403.

  13. Selberg O, Bottcher J, Tusch G, Pichlmayr R, Henkel E, Muller MJ. Identification of high- and low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters in 150 patients. Hepatology 1997; 25(3): 652-7.

  14. Richardson RA, Davidson HI, Hinds A, Cowan S, Rae P, Garden OJ. Influence of the metabolic sequelae of liver cirrhosis on nutritional intake. Am J Clin Nutr 1999; 69(2): 331-7.

  15. Davidson HI, Richardson R, Sutherland D, Garden OJ. Macronutrient preference, dietary intake, and substrate oxidation among stable cirrhotic patients. Hepatology. 1999 May;29(5):1380-1386.

  16. Aranda-Michel J. Nutrition in hepatic failure and liver transplantation. Curr Gastroenterol Rep 2001; 3(4): 362-70.

  17. Aqel BA, Scolapio JS, Dickson RC, Burton DD, Bouras EP. Contribution of ascites to impaired gastric function and nutritional intake in patients with cirrhosis and ascites. Clin Gastroenterol Hepatol 2005; 3(11): 1095-100.

  18. Stevens FM, McLoughlin RM. Is coeliac disease a potentially treatable cause of liver failure? Eur J Gastroenterol Hepatol 2005; 17(10): 1015-17.

  19. Grieco A, Miele L, Pignatoro G, Pompili M, Rapaccini GL, Gasbarrini G. Is celiac disease a confounding factor in the diagnosis of NASH? Gut. 2001; 49(4): 596.

  20. Marchesini G, Fabbri A, Bianchi G, Brizi M, Zoli M. Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis. Hepatology 1996; 23(5): 1084-92.

  21. Naveau S, Belda E, Borotto E, Genuist F, Chaput JC. Comparison of clinical judgment and anthropometric parameters for evaluating nutritional status in patients with alcoholic liver disease. J Hepatol 1995; 23(2): 234-5.

  22. Figueiredo FA, Dickson ER, Pasha TM, Porayko MK, Therneau TM, Malinchoc M, et al. Utility of standard nutritional parameters in detecting body cell mass depletion in patients with end-stage liver disease. Liver Transpl 2000; 6(5): 575-81.

  23. Hasse J. Liver Transplantation: The Benefits of Nutrition Therapy in the Liver Transplant Patient. In: Klintmalm G (ed.). Recent Developments in Transplantation Medicine. Glenview, Illinois; Physicians and Scientists Publishing Co, Inc; 1996.

  24. Hasse J. Subjective global assessment: alternative nutrition-assessment technique for liver-transplant candidates. Nutrition 1993; 9: 339-43.

  25. Schloerb PR, Forster J, Delcore R, Kindscher JD. Bioelectrical impedance in the clinical evaluation of liver disease. Am J Clin Nutr 1996; 64(3 Suppl.): 510S-514S.

  26. Fiore P, Merli M, Andreoli A, De Lorenzo A, Masini A, Ciuffa L, Valeriano V, Balotta MT, Riggio O. A comparison of skinfold anthropometry and dual-energy X-ray absorptiometry for the evaluation of body fat in cirrhotic patients. Clin Nutr 1999; 18(6): 349-51.

  27. Strauss BJ, Gibson PR, Stroud DB, Borovnicar DJ, Xiong DW, Keogh J. Total body dual X-ray absorptiometry is a good measure of both fat mass and fat-free mass in liver cirrhosis compared to “gold-standard” techniques. Melbourne Liver Group. Ann N Y Acad Sci 2000; 904: 55-62.

  28. Tran TT, Nissen N, Poordad FF, Martin P. Advances in liver transplantation. New strategies and current care expand access, enhance survival. Postgrad Med 2004; 115(5): 73-6, 79-85.

  29. Sanchez AJ, Aranda-Michel J. Liver disease and osteoporosis. Nutr Clin Pract 2006; 21(3): 273-8.

  30. Collier J. Bone disorders in chronic liver disease. Hepatology 2007; 46(4): 1271-8.

  31. Hay JE, Guichelaar MM. Evaluation and management of osteoporosis in liver disease. Clin Liver Dis 2005; 9(4): 747-66.

  32. Nakaya Y, Okita K, Suzuki K, Moriwaki H, Kato A, Miwa Y, et al. Hepatic Nutritional Therapy (HNT) Study Group. BCAA-enriched snack improves nutritional state of cirrhosis. Nutrition 2007; 23(2): 113-20.

  33. Sanchez AJ, Aranda-Michel J. Nutrition for the liver transplant patient. Liver Transpl 2006; 12(9): 1310-6.

  34. Shanbhogue RL, Bistrian BR, Jenkins RL, Randall S, Blackburn GL. Increased protein catabolism without hypermetabolism after human orthotopic liver transplantation. Surgery 1987; 101(2): 146-9.

  35. Moore FA, Feliciano DV, Andrassy RJ, McArdle AH, Booth FV, Morgenstein-Wagner TB, et al. Early enteral feeding, compared with parenteral, reduces postoperative septic complications. The results of a meta-analysis. Ann Surg 1992; 216(2): 172-83.

  36. Hasse JM, Blue LS, Liepa GU, Goldstein RM, Jennings LW, Mor E, Husberg BS, Levy MF, Gonwa TA, Klintmalm GB. Early enteral nutrition support in patients undergoing liver transplantation. JPEN J Parenter Enteral Nutr. 1995 Nov-Dec;19(6):437-443.

  37. Stegall MD, Everson G, Schroter G, Bilir B, Karrer F, Kam I. Metabolic complications after liver transplantation. Diabetes, hypercholesterolemia, hypertension, and obesity. Transplantation. 1995; 60(9): 1057-60.

  38. Richards J, Gunson B, Johnson J, Neuberger J. Weight gain and obesity after liver transplantation. Transpl Int 2005;18(4): 461-6.

  39. Abouljoud MS, Levy MF, Klintmalm GB, US Multicenter Study Group. Hyperlipidemia after liver transplantation: long-term results of the FK506/cyclosporin A US Multicenter trial. Transplant Proc 1995; 27: 1121-3.

  40. Munoz SJ, Deems RO, Moritz MJ, Martin P, Jarrell BE, Maddrey WC. Hyperlipidemia and obesity after orthotopic liver transplantation. Transplant Proc 1991; 21: 1480-83.

  41. Eid A, Steffen R, Porayko MK, Beer TF, Kaese DE, Wiesner RH, et al. Beyond one year after liver transplantation. Mayo Clin Proc 1989; 64: 446-50.

  42. Mirabella S, Brunati A, Ricchiuti A, Pierini A, Franchello A, Salizzoni M. New-onset diabetes after liver transplantation. Transplant Proc 2005; 37(6): 2636-7.

  43. Millonig G, Graziadei IW, Eichler D, Pfeiffer KP, Finkenstedt G, Muehllechner P, et al. Alendronate in combination with calcium and vitamin D prevents bone loss after orthotopic liver transplantation: a prospective single-center study. Liver Transpl 2005; 11(8): 960-6.

  44. Stein E, Ebeling P, Shane E. Post-transplantation osteoporosis. Endocrinol Metab Clin North Am 2007; 36(4): 937-63.




2020     |     www.medigraphic.com